Transcriptomic signature of Bexarotene (Rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models

• Main Authors: Bissonnette Reid P (Author), Hill Jamal (Author), Zhang Yun (Author), Kittrell Frances S (Author), Gaddis Sally (Author), Levy Carla C (Author), Hu Yuhui (Author), Abba Martin C (Author), Medina Daniel (Author), Brown Powel H (Author), Aldaz C (Author)
• Format: Book
• Published: BMC, 2008-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>The rexinoid bexarotene (LGD1069, Targretin) is a highly selective retinoid × receptor (RXR) agonist that inhibits the growth of pre-malignant and malignant breast cells. Bexarotene was shown to suppress the development of breast can...